A multicentre, randomized, single ‐blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once‐daily gel versus clindamycin 1% twice‐daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients

ConclusionCDP/BPO gel demonstrated superior efficacy over CDP gel along with acceptable safety and tolerability in Chinese patients with mild to moderate acne.
Clinical Trials.gov number: NCT01915732

Source: Journal of the European Academy of Dermatology and Venereology - April 12, 2016 Category: Dermatology Authors: J.H. Xu, Q.J. Lu, J.H. Huang, F. Hao, Q.N. Sun, H. Fang, J. Gu, X.Q. Dong, J. Zheng, D. Luo, F.Q. Li, G. Wang, H. Gu, H.Q. Tian, H.L. Yang, L.Y. Xi, M. Li, M. Zheng, Y. Wu, Y.T. Tu, Y.L. He, G. Zhao, W.X. Sheng, J. Li, A.G. Hamedani Tags: Original Article Source Type: research